Royal North Shore Hospital’s Associate Professor Brendon Neuen will establish an international consortium to support those with both heart and kidney disease. The nephrologist and Director of Kidney Trials will lead the collaboration after being awarded close to $500,000 from NSW Health through a program to drive groundbreaking projects in heart disease. The grant will support the establishment of .....
Read more

An innovative tool which could revolutionise the detection and treatment of musculoskeletal and neurological conditions will be further developed following a $230,000 gift. The donation was made following a campaign by the University of Sydney’s Advancement team and the NORTH Foundation to support the world’s first open-source dataset of whole-body muscle composition. The Kolling Institute’s Academ.....
Read more

The burble of high-powered motorcycles was heard across the Kolling Institute forecourt as part of a 2000 kilometre ride from Melbourne to Armidale to raise awareness and funds for life-changing research. The ride is an initiative of Robert Hunt from the Ulysses Club which has been supporting rheumatoid arthritis research for nearly three decades. The late Stephen Dearnley established the club in 1.....
Read more

A federal government funding boost will pave the way for a much-needed, tailored program for culturally diverse communities experiencing musculoskeletal pain. Dr Saurab Sharma, the Chief Clinical Scientist from the Pain Management and Research Centre at Royal North Shore Hospital, has received a National Health and Medical Research Council investigator grant to progress his research and develop an .....
Read more

A two-decade long commitment to reducing blood cancers has delivered coveted national funding to Associate Professor Jenny Wang to progress her vital cancer research. As the head of the Kolling Institute’s Cancer and Stem Cell Laboratory, Associate Professor Wang has secured a $2.95 million investigator grant from the National Health and Medical Research Council to advance her pioneering research i.....
Read more

A $3-million research grant will help develop technology to identify frailty in older people in hospital, a crucial step towards improving care and long-term patient outcomes. The Kolling Institute’s Professor Sarah Hilmer will lead the large-scale study involving hospitals and universities across Australia as well as international investigators. Professor Hilmer said the five-year project will dev.....
Read more

An innovative partnership with industry will see our researchers at the Kolling Institute develop evidence-based strategies to improve osteoarthritis management in Australia and globally. Consumer healthcare company Haleon is sponsoring a five-year fellowship to investigate the role of supplements in managing osteoarthritis and digital health technologies to improve mobility. Osteoarthritis is a le.....
Read more

Generous community support is strengthening our research into oesophageal cancer, lifting hopes of improved treatments for the aggressive and deadly cancer. The Fight for a Cure charity has donated $100,000 towards Dr Colby Stevenson’s research, on top of a $100,000 donation from the Howlett family, in memory of their son Scott who died from the cancer. The Howlett family has welcomed the research .....
Read more

Researchers at the Kolling Institute have welcomed the launch of Australia's premier cancer clinical trials centre on the Royal North Shore Hospital campus. NORTH Sydney Trials and Research Van Norton Poche or NORTH STAR VNP has been made possible by a $20 million gift from the late Kay Van Norton Poche and her husband Greg. The centre is a ground-breaking partnership between Northern Sydney Local .....
Read more

Our ground-breaking leukaemia research at the Kolling Institute has received an important boost with the Cancer Council NSW announcing a $450,000 grant for Associate Professor Jenny Wang and her research team. The funds will help the development of a new therapy to greatly improve survival rates for those with acute myeloid leukaemia. This form of blood cancer is particularly aggressive, with less .....
Read more